In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Alice Biggane, Outcomes Innovation and Research Lead at Pfizer UK, to discuss how various PRO measures inform and impact reimbursement decisions for HTA driven markets. Together they unpack what data sources and methods exist for the quantification and understanding of HRQoL for cost-effectiveness decision making and the complex interplay between the need to reduce burden and increase transparency through standardization, while maintaining the crucial and nuanced balance of different stakeholder requirements. Tune in to learn how leading organizations are working to build more inclusive, efficient, and patient-focused clinical trials, and accelerating patient-access to new health technologies.

In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, is joined by Jonathan Norman, Director of Translation and Localization at YPrime, for an in-depth discussion on the realities of eCOA libraries. Together, they explore why “libraries” are more accurately described as asset repositories, the conditions under which reuse can meaningfully accelerate study timelines, and the limitations that prevent them from being a universal solution. The conversation highlights both the efficiencies and challenges of reuse, providing clarity on how sponsors and providers can better align expectations in clinical trial execution.

In this tech-forward episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, welcomes Indira Jain-Figueroa, Product Director at Evinova, for a deep dive into the ever-evolving landscape of eCOA development. Covering everything from cross-platform development, backups, and emulator use to the future role of AI in reporting, this conversation highlights how innovation can improve both user experience and study efficiency in clinical trials.

Artificial intelligence is redefining what’s possible across the clinical development lifecycle, but with rapid innovation comes the need for thoughtful oversight. In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Richard “RJ” Kedziora, Co-Founder of Estenda Solutions, to explore how AI is transforming clinical research and digital health. From scaling informed consent through digital avatars to detecting patient emotion using voice and behavioral cues, they dive into the practical applications, ethical challenges, and future potential of AI in patient-centric trials.

In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Elizabeth (Nicki) Bush, Executive Director and Global Head of Endpoint Strategy and COA Measurement at OPEN Health Group to discuss the growing complexity of collecting and interpreting patient data. With insights from the recent FDA workshop around Patient-Focused Drug Development (PFFD), the two discuss the importance of integrating measurement science early in the study design, improving data quality while minimizing patient burden, and ensuring patient data is not just gathered, but meaningfully applied in regulatory submissions.

In this episode of LifeSci Talks, TransPerfect’s Global Practice Leader Mark Wade sits down with Dr. Karl McEvoy, VP of eCOA and Patient Technology at YPrime, to discuss the importance of embracing technology in clinical research to reduce the patient burden. The two cover everything from updating legacy instruments to more modern solutions such as using video assessments, to incorporating caregiver and patient advocacy groups input for reshaping trial design. Listen in for insights on strategies that balance data collection with the demands of an ever-evolving global clinical landscape to drive meaningful outcomes.

In this episode of LifeSci Talks, TransPerfect Life Sciences’ Global Practice Leader Mark Wade sits down with Kelly Dumais PhD, Director of eCOA Science at Clario to discuss the significance rater training plays in standardizing the administration and scoring of clinical scales. Aiming to reduce bias and enhance data quality, you’ll hear about potential strategies for better engaging patients and how comprehensive proactive training can reduce patient and site burden. Listen to key insights around developing training programs as the two dive into the importance of standardized rater training across diverse clinical settings for maintaining data quality.